Generic cholesterol drug OK'd
Patients may face switch from Zocor
June 24, 2006
With Friday's decision by federal regulators to approve a generic version of Zocor, one of the world's best-selling, cholesterol-lowering drugs, consumers now face a decision: Should they switch to a cheaper medicine?
For consumers who pay for their drugs out of pocket, using generic statins might save them as much as $1,800 a year, according to a report posted Thursday by Consumer Reports at www.crbestbuydrugs.com.cqaustin
Even those with prescription drug benefits likely will save $200-$300 a year in co-pays, the report said.
Simvastin, the drug approved Friday, is the generic form of Zocor, which generated $4.4 billion in worldwide sales last year. Lipitor, made by Pfizer Inc., is the best selling drug in the world with $12 billion in sales last year.
沒有留言:
張貼留言